Strategic Assay Selection for analytics in high‐throughput process development: Case studies for downstream processing of monoclonal antibodies
02:24 EDT 9 Aug 2012 | Wiley Biotechnology Journal
During bioprocess development a potentially large number of analytes require measurement. Selection of the best set of analytical methods to deploy can reduce the analytical requirements for process investigation but currently relies on application o..
Original Article: Strategic Assay Selection for analytics in high‐throughput process development: Case studies for downstream processing of monoclonal antibodies
More From BioPortfolio on "Strategic Assay Selection for analytics in high‐throughput process development: Case studies for downstream processing of monoclonal antibodies"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
